Field Trip Health & Wellness Ltd

Field Trip Health & Wellness Ltd. develops and delivers psychedelic therapies. The psychedelic therapies are utilized in the treatment of mental health and mood disorders such as severe depression, anxiety, and post-traumatic stress disorder. The company was founded on April 28, 2022 and is headquartered in Toronto, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

TORONTO, March 22, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) (“Field Trip” or the “Company”) today announced that it has obtained an Order (the “Initial Order”) for creditor protection from the Ontario Superior Court of Justice (Commercial List) (the “Court”) under the Companies' Creditors Arrangement Act (the “CCAA”). PricewaterhouseCoopers Inc. has been appointed as the CCAA monitor (the “Monitor”).

Field Trip Health & Wellness Obtains CCAA Protection

TORONTO, March 15, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”) today announced that, in an effort to reduce expenditures and preserve capital, it will be closing the Field Trip Health Centres located in Chicago, Washington DC, Seattle, San Diego and Fredericton. The anticipated last day of operation for each of these locations will be on or around April 15, 2023.

Field Trip Health & Wellness to Close Clinics in 5 Locations

TORONTO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (OTCQB: FTHWF) (the "Company" or "Field Trip"), a global leader in the delivery of psychedelic therapies, provided a business update today and reported its fiscal third quarter 2023 results for the three and nine month periods ended December 31, 2022. All results are reported in accordance with International Financial Reporting Standards and in Canadian dollars, unless otherwise specified.

Field Trip Health & Wellness Provides Business Update and Reports Fiscal Third Quarter 2023 Results

TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (OTCQB: FTHWF) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 third quarter ended December 31, 2022, after market close on Tuesday, February 28, 2023.

Field Trip Health & Wellness Ltd. to Release Fiscal 2023 Third Quarter Financial Results on Tuesday, February 28, 2023

Trading on the OTCQB Effective February 2, 2023, under the Symbol “FTHWF” Trading on the OTCQB Effective February 2, 2023, under the Symbol “FTHWF”

Field Trip Health & Wellness Announces Posting on the OTC Market

Reunion Neuroscience Inc

When will capital markets catch up to psychedelic industry? Ronan Levy, CEO and Co-Founder of Field Trip, discusses strategy behind focusing on ketamine assisted therapy.

Psychedelic Sunday: Ketamine Assisted Therapy

The new program, which builds on Field Trip's clinically proven ketamine therapies, will provide people with a non-ordinary approach to psychotherapy The new program, which builds on Field Trip's clinically proven ketamine therapies, will provide people with a non-ordinary approach to psychotherapy

Field Trip Health & Wellness Ltd. Announces Launch of Online Therapy

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, today provided a business update and reported fiscal second quarter 2023 results for the three-month period ended September 30, 2022. All results are reported under International Financial Reporting Standards ("IFRS") and in Canadian dollars, unless otherwise specified.

Field Trip Health & Wellness Provides Business Update And Reports Fiscal Second Quarter 2023 Results

Management to Hold Fiscal Second Quarter 2023 Conference Call on Wednesday, November 30, 2022, at 8:30 AM ET Management to Hold Fiscal Second Quarter 2023 Conference Call on Wednesday, November 30, 2022, at 8:30 AM ET

Field Trip Health & Wellness Ltd. Announces Updated Time for Fiscal Second Quarter 2023 Financial Results and Conference Call

Field Trip Health Ltd

Appoints Stacey Hoisak as Senior Vice President, General Counsel, and Dr. Monique Moller as Vice President, Integrative Health Schedules Fiscal Second Quarter 2023 Conference Call for Tuesday, November 29, 2022, at 8:30 AM ET

Field Trip Health & Wellness Ltd. Strengthens Leadership Team With Two Executive Appointments, Schedules Fiscal Second Quarter 2023 Conference Call

TORONTO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in the development and delivery of psychedelic therapies, today released the following letter to shareholders from the Company's Chairman & Chief Executive Officer, Ronan Levy, and President, Mujeeb Jafferi.

Field Trip Health & Wellness Releases Letter to Shareholders

TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, today announced it will participate in a virtual fireside chat at Cantor Fitzgerald's “Symposium on Mental Health Clinics,” taking place on Tuesday, October 11, 2022.

Field Trip Health & Wellness to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics on October 11th

Announces Grant of Stock Options to Directors and Officers Announces Grant of Stock Options to Directors and Officers

Field Trip Health & Wellness to Present at the H.C. Wainwright 24th Annual Global Investment Conference

TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first quarter for the three-month period ended June 30, 2022, after market close on Monday, August 29, 2022.

Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M.

News for Field Trip Health & Wellness Ltd Stock (FTHWF)